50 Results for "

5-HT 2a receptor

" in MedChemExpress (MCE) Product Catalog:
Products (50)

50 Results for "5-HT 2a receptor" in MCE Product Catalog:

12
12 Publications Verification
Cat. No.: HY-14557A
CAS No.: 706782-28-7
Purity:  99.91%
Synonyms: ACP-103 hemitartrate
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Pimavanserin (ACP-103) hemitartrate is a potent and brain-penetrant5-HT 2A receptor inverse agonist with pIC50 and pKi of 8.73 and 9.3, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N1957
CAS No.: 31271-07-5
Synonyms: γ-Mangostin
Gamma-Mangostin is a novel competitive 5-hydroxytryptamine 2A (5-HT2A) receptor antagonist and potent epoxidase 2 (COX-2) inhibitor, as well as a transthyroxin protein (TTR) profibrosis inhibitor. Gamma-Mangostin binds to the thyroxine (T4)-binding sites and stabilized the TTR tetramer . Gamma-Mangostin inhibits [3 H] spiperone binding to cultured rat aortic myocytes (IC50=3.5 nM) and reduces The perfusion pressure response of rat coronary artery to 5-HT2A (IC50=0.32 μM). Gamma-Mangostin has anti-inflammatory, antibacterial, antioxidant and anticancer activities, and can be used in the study of metabolic disorders such as diabetes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-A0019A
CAS No.: 199739-10-1
Synonyms: 9-Hydroxyrisperidone palmitate
Research Areas:  

Neurological Disease

Paliperidone palmitate is an orally effective competitive antagonist of dopamine D2 receptors and 5-hydroxytryptamine 2A (5-HT2A) receptors that can cross the blood-brain barrier. Paliperidone palmitate competitively inhibits the effects of dopamine and 5-hydroxytryptamine by binding to dopamine D2 receptors and 5-HT2A receptors, regulating the balance of the neurotransmitter system and thus exerting antipsychotic activity. Paliperidone palmitate is mainly used in the research field of schizophrenia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145393
CAS No.: 2698331-34-7
Purity:  99.94%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT2A receptor agonist-1 (Compound 3) is a selective 5-HT2A receptor agonist with the EC50 of 5.54 nM. 5-HT2A receptor agonist-1 can be used for the research of mood disorders .
loading...
    loading...
Cat. No.: HY-109067A
CAS No.: 1440796-75-7
Purity:  99.62%
Synonyms: VVZ-149 hydrochloride
Research Areas:  

Neurological Disease

Opiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. Opiranserin hydrochloride shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin hydrochloride is development as an injectable agent for the treatment of postoperative pain .
loading...
    loading...
Cat. No.: HY-153912
CAS No.: 1391499-52-7
Purity:  98.53%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT2A receptor agonist-3 ((S,S)-9b) is a 5-HT2A receptor agonist with a Ki of 2.5 nM for human 5-HT2A receptor. 5-HT2A receptor agonist-3 shows 124-fold selectivity for 5-HT2A over the structurally similar 5-HT2C receptor .
loading...
    loading...
Cat. No.: HY-175511
CAS No.: 2864368-10-3
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT2A agonist 7 (Compound 45) is an orally active and highly selective serotonin receptor 2A (5-HT2A) agonist (EC50=12 nM). 5-HT2A agonist 7 is promising for research of psychiatric disorders such as depression .
loading...
    loading...
Cat. No.: HY-168809
CAS No.: 21420-59-7
Research Areas:  

Neurological Disease

Norbaeocystin is an intermediate/minor metabolite naturally present in the psilocybin biosynthetic pathway of hallucinogenic mushrooms (Psilocybe spp.). Norbaeocystin has weak or no affinity for the serotonin 2A (5-HT2A) receptor and does not induce receptor activation. Norbaeocystin is rapidly metabolized by monoamine oxidase, and thus does not participate in centrally mediated psychedelic effects. Norbaeocystin can be used for studies on biological pathways associated with hallucinogenic effects .
loading...
    loading...
Cat. No.: HY-109067
CAS No.: 1441000-45-8
Synonyms: VVZ-149
Research Areas:  

Neurological Disease

Opiranserin (VVZ-149), a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. Opiranserin shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin is development as an injectable agent for the treatment of postoperative pain .
loading...
    loading...
Cat. No.: HY-19950
CAS No.: 1028307-48-3
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT2A receptor agonist-6 (compound 47) is a selective 5-HT2A receptor agonist (pEC50=6.58) .
loading...
    loading...
Cat. No.: HY-172995
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

RS130-180 is a selective β-arrestin-biased agonist targeting the serotonin 2A receptor (5-HT2aR). RS130-180 is promising for research of neuropsychiatric disorders such as depression .
loading...
    loading...
Cat. No.: HY-145841
CAS No.: 528525-37-3
Target:  

5-HT Receptor

Research Areas:  

Cardiovascular Disease

5-HT2A receptor agonist-2 is a highly potent serotonin 5-HT2 receptor agonists. 5-HT2A receptor agonist-2 inspires 5-HT2A, 5-HT2B, and 5-HT2C with EC50 values of 1.7, 0.58, and 0.50 nM, respectively .
loading...
    loading...
Cat. No.: HY-101622
CAS No.: 131999-28-5
Research Areas:  

Neurological Disease

5-HT6/7 antagonist 1 is a multifunctional ligand that antagonizes 5-HT6/7/2A and D2 receptors, without interacting with M1 receptors and hERG channels.
loading...
    loading...
Cat. No.: HY-W1123900
CAS No.: 2945111-66-8
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT2A agonist 3 (Compound P-141) is a selective 5-hydroxytryptamine 2A receptor (5-HT2A) agonist with an EC50 value of 13.80 nM. 5-HT2A agonist 3 is promising for research of mental illnesses such as depression, post-traumatic stress disorder, obsessive-compulsive disorder, and central nervous system disorders .
loading...
    loading...
Cat. No.: HY-175285
CAS No.: 780703-57-3
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT2AR-IN-1 (Compound Ie) is an orally active 5-hydroxytryptamine 2A receptor (5-HT2AR) inhibitor with antidepressant efficacy. 5-HT2AR-IN-1 reduces 5-HT2AR expression and SERT protein levels. 5-HT2AR-IN-1 is promising for research of central nervous system (CNS), such as depression and addiction-related disorders .
loading...
    loading...
Cat. No.: HY-A0019AS
CAS No.: 1794685-21-4
Synonyms: 9-Hydroxyrisperidone palmitate-d4
Paliperidone palmitate-d4 (9-Hydroxyrisperidone palmitate-d4) is the deuterium labeled Paliperidone palmitate (HY-A0019A). Paliperidone palmitate is an orally effective competitive antagonist of dopamine D2 receptors and 5-hydroxytryptamine 2A (5-HT2A) receptors that can cross the blood-brain barrier. Paliperidone palmitate competitively inhibits the effects of dopamine and 5-hydroxytryptamine by binding to dopamine D2 receptors and 5-HT2A receptors, regulating the balance of the neurotransmitter system and thus exerting antipsychotic activity. Paliperidone palmitate is mainly used in the research field of schizophrenia .
loading...
    loading...
Cat. No.: HY-165527
CAS No.: 200398-40-9
Research Areas:  

Neurological Disease

S18327 is a multi-target antipsychotic agent. S18327 exerts its efficacy by acting on multiple neurotransmitter systems in the brain, and it has antagonistic effects on dopamine receptors (particularly the D2 receptor) and 5-hydroxytryptamine 2A receptors (5-HT2A receptor). S18327 can counteract excessive dopamine activity and hypo-function of glutamate. S18327 exhibits a multi-parameter pharmacological profile that is highly similar to that of Clozapine (HY-14539). S18327 can produce the same discriminative stimulus as Clozapine, improve cognitive filtering deficits associated with schizophrenia, and display anxiolytic properties. S18327 has relatively weak affinity for histaminergic receptors and muscarinic receptors, which avoids the side effects of Clozapine .
loading...
    loading...
Cat. No.: HY-N1957R
CAS No.: 31271-07-5
Synonyms: γ-Mangostin (Standard)
Gamma-Mangostin (Standard) is the analytical standard of Gamma-Mangostin. This product is intended for research and analytical applications. Gamma-Mangostin is a novel competitive 5-hydroxytryptamine 2A (5-HT2A) receptor antagonist and potent epoxidase 2 (COX-2) inhibitor, as well as a transthyroxin protein (TTR) profibrosis inhibitor. Gamma-Mangostin binds to the thyroxine (T4)-binding sites and stabilized the TTR tetramer . Gamma-Mangostin inhibits [3H] spiperone binding to cultured rat aortic myocytes (IC50=3.5 nM) and reduces The perfusion pressure response of rat coronary artery to 5-HT2A (IC50=0.32 μM). Gamma-Mangostin has anti-inflammatory, antibacterial, antioxidant and anticancer activities, and can be used in the study of metabolic disorders such as diabetes .
loading...
    loading...
Cat. No.: HY-175657
CAS No.: 2956765-08-3
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT2A receptor agonist-12 (compound 161-2) is a potent 5-HT2A agonist with an EC50 value of <100 nM for h5-HT2A .
loading...
    loading...
Cat. No.: HY-179063
5-HT2A receptor agonist-13 (Compound 28c) is a partial agonist of the 5-HT2A receptor, with an EC50 value of 416.9 nM and a Ki value of 113.9 nM. 5-HT2A receptor agonist-13 exhibits very weak agonistic activity towards the 5-HT2B receptor (EC50 = 120.2 nM), D2 receptor (Ki = 1298 nM), and has no activity towards the 5-HT2C receptor. 5-HT2A receptor agonist-13 exhibits weak inhibitory activity on the serotonin transporter (SERT) (EC50 = 977.2 nM). 5-HT2A receptor agonist-13 has antidepressant activity in mouse models and does not induce hallucinogenic behavior. 5-HT2A receptor agonist-13 can be used for the study of major depressive disorder (MDD) and treatment-resistant depression (TRD) .
loading...
    loading...